Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E57.79 EPS (ttm)0.67 Insider Own0.30% Shs Outstand1.48B Perf Week-0.80%
Market Cap56.74B Forward P/E15.85 EPS next Y2.43 Insider Trans29.41% Shs Float1.46B Perf Month0.13%
Income993.00M PEG5.84 EPS next Q0.65 Inst Own74.40% Short Float5.14% Perf Quarter-8.27%
Sales20.71B P/S2.74 EPS this Y53.50% Inst Trans1.09% Short Ratio8.99 Perf Half Y-0.04%
Book/sh14.07 P/B2.73 EPS next Y9.88% ROA3.40% Target Price47.38 Perf Year-13.03%
Cash/sh3.05 P/C12.59 EPS next 5Y9.90% ROE6.60% 52W Range35.34 - 45.50 Perf YTD-12.27%
Dividend1.04 P/FCF190.39 EPS past 5Y-10.30% ROI7.70% 52W High-15.54% Beta1.35
Dividend %2.71% Quick Ratio1.20 Sales past 5Y-10.30% Gross Margin56.90% 52W Low8.75% ATR0.76
Employees74000 Current Ratio1.60 Sales Q/Q3.00% Oper. Margin14.70% RSI (14)41.89 Volatility1.53% 2.05%
OptionableYes Debt/Eq0.38 EPS Q/Q-161.10% Profit Margin6.60% Rel Volume1.14 Prev Close37.90
ShortableYes LT Debt/Eq0.29 EarningsJan 18 BMO Payout112.60% Avg Volume8.37M Price38.43
Recom1.90 SMA20-2.19% SMA50-4.60% SMA200-5.10% Volume9,514,632 Change1.40%
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Dec-05-16 08:20AM  4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential at 24/7 Wall St.
Dec-02-16 02:46PM  MedTech Sails Through Macro Woes: Stocks in Focus
08:05AM  Boston Scientific Completes Its Acquisition of EndoChoice
Dec-01-16 08:10AM  Analysts Top Pharmaceutical Buys Offer Big Dividends and Growth Potential at 24/7 Wall St.
Nov-30-16 02:03PM  Abbott's i-STAT Alinity Received CE Mark
07:00AM  Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform PR Newswire
Nov-29-16 11:04AM  What Really Disrupted Medtronics Diabetes Segment Sales in Fiscal 2Q17?
09:16AM  The Best Obamacare Stocks of 2016 at Motley Fool
Nov-25-16 03:59PM  Is Time Warner Inc (TWX) Right for Your Portfolio? at Insider Monkey
11:58AM  Abbott: $15 Billion Available From Notes
Nov-23-16 01:11PM  The Smart Moneys Confidence in Abbott Laboratories (ABT) Continues to Rise at Insider Monkey
12:24PM  Goldman Sachs' Most Meaningful Short Positions List
12:20PM  EU regulator conditionally approves Abbott's purchase of St Jude
09:01AM  ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
07:59AM  [$$] Abbott Labs CEO Doubles His Stock Holdings at
Nov-22-16 10:41PM  Asian stocks rise after Dow hits record
Nov-21-16 11:04AM  Exploring the Nuances of Strykers Cost Transformation for Growth
10:04AM  How Is Stryker Moving Forward with International Growth?
08:04AM  How Are Strykers Core Strategies Working Toward Its Growth?
Nov-20-16 10:20AM  Massive Energy and Health Care Trades Highlight Insider Buying: Abbott Labs, Baker Hughes, Datawatch, Impac Mortgage and More at 24/7 Wall St.
Nov-18-16 07:16PM  Cramer's lightning round: This pharma stock is nothing but a giant headache at CNBC
11:35AM  Weak Outlook on Mylan
Nov-17-16 10:32AM  Abbott Laboratories -- Moody's assigns Baa3 to Abbott's new senior notes; existing ratings remain on review for downgrade at Moody's
09:07AM  ABBOTT LABORATORIES Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Abbott and Alere Need to Keep Talking at Bloomberg
05:45AM  [$$] Abbott, St. Jude Medical to Sell $1.1 Billion in Assets at The Wall Street Journal
Nov-16-16 05:22PM  ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers
04:04PM  How Has Medtronics Stock Performed Recently?
01:51PM  Most Analysts Rate Novartis a Buy
01:29PM  5 Stocks Insiders Love Right Now
09:19AM  European Union Regulators Said to Approve Abbott's St. Jude Acquisition
Nov-15-16 06:52PM  Alere Shares Rise After Abbott Deal on Bribery-Probe Records at Bloomberg
05:52PM  Exclusive: EU regulators seen clearing $25 billion Abbott, St Jude deal: source
10:20AM  Abbott Laboratories CEO Buys Stock in Company
Nov-14-16 01:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $15 Million of Shares
01:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $2 million of Shares
01:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $4.9 million of Shares
01:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $3.6 million of Shares
01:15PM  Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $2.1 million of Shares
08:04AM  The Performance of AstraZenecas Growth Platforms in 3Q16
Nov-11-16 08:30AM  14 Stocks And 4 ETFs To Capitalize On The Trump Transition at Forbes
Nov-10-16 01:04PM  ABBOTT LABORATORIES Financials
Nov-07-16 05:00PM  Abbott Labs: Absorb Heart Stent Approved in Japan
07:00AM  Abbott's Absorb Bioresorbable Stent Approved as the First Fully Dissolving Heart Stent in Japan PR Newswire
Nov-06-16 10:05AM  Massive Icahn Trade Highlights Insider Buying: Herbalife, CBRE, Colliers International, Freeport McMoRan, NuVasive and More at 24/7 Wall St.
Nov-05-16 01:00PM  Weekly Top Insider Buys Highlight for Week of November 4
Nov-04-16 03:58PM  [$$] Alere Shares Fall on Disappointing Quarterly Report at The Wall Street Journal
03:52PM  Another Rock Falls on Alere-Abbott Merger
03:42PM  Alere stock plunges after division allegedly submitted claims for dead patients at
03:35PM  Alere Inc. Has Been Left for Dead, With Its Shares Down 13% at Motley Fool
12:51PM  Abbott Laboratories (ABT) Dragging Alere Inc (ALR) To Court at Insider Monkey
08:58AM  Mairs & Power Adds Alphabet (GOOGL), Thinks Wells Fargo (WFC) Has Been Overly Punished at Insider Monkey
Nov-03-16 07:18PM  Abbott Files Breach of Contract Suit Against Alere
04:29PM  ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report
12:46PM  Abbott offers EU concessions over $25 billion St. Jude deal Reuters
12:42PM  Abbott offers EU concessions over $25 bln St Jude deal Reuters
12:11PM  Dividend Aristocrats in Focus Part 29: Abbott Laboratories
Nov-02-16 08:06AM  Thermo Fisher Scientific Updated Its 2016 Guidance
Nov-01-16 01:53PM  AbbVie Reports 3rd Quarter Results
11:06AM  Analyzing Thermo Fisher Scientifics Recent Stock Performance
08:35AM  Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now at 24/7 Wall St.
Oct-31-16 01:17PM  Mairs & Power Growth Fund 3rd Quarter Results
07:46AM  George Soros Isnt Just A Controversial Political Figure; He Also Owns A Lot of Stocks, And These Are His Long-Term Favorites at Insider Monkey
Oct-28-16 12:28PM  St. Jude halts certain pacemaker implants over data issue
Oct-27-16 02:00PM  A Great Place to Work, According to Science PR Newswire
11:22AM  Oh Baby! Can Mead Johnson Keep Growing Sales In China? at
Oct-26-16 04:11PM  St. Jude Medical Shareholders Approve Merger with Abbott Business Wire
02:00PM  New Study: Babies Fed Infant Formula with 2'-FL Human Milk Oligosaccharide+ Had Immune Response More Like Breastfed Babies PR Newswire
12:04PM  Becton, Dickinson and Companys 4Q16 Earnings Estimates
08:05AM  Analysts Recommendations for Abbott Laboratories
Oct-25-16 04:04PM  Abbott Laboratories Updated Guidance for 2016
03:04PM  Abbott Laboratories: What Offset Weak Nutrition Sales?
02:26PM  ETFs with exposure to Abbott Laboratories : October 25, 2016
12:46PM  Why Did the Nutrition Segments Performance Fall?
12:46PM  Abbotts Stock Prices Fell despite Strong 3Q16 Results
12:44PM  Abbott Laboratories : ABT-US: Dividend Analysis : October 14th, 2016 (record date) : By the numbers : October 25, 2016
08:27AM  Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More
Oct-24-16 05:05PM  ABBOTT LABORATORIES Files SEC form 8-K, Other Events
03:00PM  Abbott Labs Is Likely to See Further Weakness
01:15PM  UPDATE 1-Hired experts support claims St. Jude heart devices can be hacked Reuters
11:04AM  Major Developments for Johnson & Johnson in 3Q16
09:59AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016
09:46AM  Muddy Waters says outside experts found St Jude devices can be hacked Reuters
09:30AM  The Zacks Analyst Blog Highlights: Abbott, Goldman Sachs, Verizon and Union Pacific
Oct-23-16 03:56PM  Alere's Shareholders Approve Merger With Abbott
Oct-21-16 06:04PM  JNJ Moved to Restructure Its Medical Devices Business in 3Q16
11:44AM  Top Research Reports for Goldman Sachs, Verizon, Abbott & Others
11:09AM  Earnings show signs of life
10:05AM  A Look at Johnson & Johnsons Segment-Wise Performance in 3Q16
Oct-20-16 05:48PM  Another Health Care Chart Looks Sick
05:28PM  Abbott, St. Jude Medical: Agreement Reached in Sale of Vascular Closure Products toTerumo
01:41PM  Amid Headline Risk, Barclays Says St. Jude's Pipeline Underestimated
11:17AM  People's Republic of China Clears Abbott Acquisition of Alere PR Newswire
09:17AM  Abbott, St. Jude Divests $1B in Assets (ABT, STJ) at Investopedia
Oct-19-16 10:14PM  [$$] Abbott Labs Swings to Loss After Booking Charge on Mylan Stake at The Wall Street Journal
05:59PM  Abbott Releases 3rd Quarter Results
04:18PM  Abbott Labs, St. Jude Lurch On Muddy Waters Tussle Despite Q3 Sales Beats
03:14PM  Abbott Labs (ABT) Beats on Q3 Earnings, Narrows 2016 View
01:19PM  Drug Wars: California Vote Could Limit Price Hikes at Investopedia
12:48PM  Abbott moves ahead on St. Jude, Alere deals, but investors fret Reuters
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM
WHITE MILES DChairman and CEODec 16Option Exercise21.22438,0009,294,0971,832,153Dec 18 05:01 PM
WHITE MILES DChairman and CEODec 16Sale46.00438,00020,149,9581,394,153Dec 18 05:01 PM